Bone health nutraceuticals alter microarray mRNA gene expression: A randomized, parallel, open-label clinical study

Phytomedicine

Volumn 23, Issue 1, 2016, Pages 18-26

  Lin, Yumei ^a,d   Kazlova, Valentina ^a   Ramakrishnan, Shyam ^a,c   Murray, Mary A ^a   Fast, David ^b   Chandra, Amitabh ^b   Gellenbeck, Kevin W ^a  

^a Nutrilite   (United States)

^b Access Business Group LLC   (United States)

^c Himalaya Health Care   (India)

^d Yumei Consulting   (United States)

Author keywords

Bone morphogenetic protein 2; Botanical extracts; Microarray analysis; Receptor activator of nuclear factor kappa B ligand

Indexed keywords

PLANT EXTRACT;

BONE DEVELOPMENT; CONTROLLED STUDY; DIETARY SUPPLEMENT; DRUG EFFECTS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; METABOLISM; MICROARRAY ANALYSIS; MIDDLE AGED; OSTEOLYSIS; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL;

BONE RESORPTION; DIETARY SUPPLEMENTS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; MICROARRAY ANALYSIS; MIDDLE AGED; OSTEOGENESIS; PLANT EXTRACTS; POSTMENOPAUSE;

EID: 84952927374     PISSN: 09447113     EISSN: 1618095X     Source Type: Journal    
DOI: 10.1016/j.phymed.2015.11.011     Document Type: Article

References (30)

1. Behr B., Leucht P., Longaker M.T., Quarto N. Fgf-9 is required for angiogenesis and osteogenesis in long bone repair Proc. Natl. Acad. Sci. USA 107 2010 11853 11858
2. Deschaseaux F., Sensebe L., Heymann D. Mechanisms of bone repair and regeneration Trends Mol. Med. 15 2009 417 429
3. Dvornyk V., Liu Y., Lu Y., Shen H., Lappe J.M., Lei S., Recker R.R., Deng H. Effect of menopause on gene expression profiles of circulating monocytes: a pilot in vivo microarray study J. Genet. Genomics 34 2007 974 983
4. Fast D., Chandra A., Lin Y., Murray M.A., Gellenbeck K. Novel approach for screening natural plant ingredients for development of nutraceutical bone health supplements Carkeet C. Grann K. Randolph R.K. Venzon D.S. Izzy S.M. Phytochemicals: Health Promotion and Therapeutic Potential 2013 CRC Press Boca Raton, FL 73 93
5. Fox S.W., Evans K.E., Lovibond A.C. Transforming growth factor-beta enables NFATc1 expression during osteoclastogenesis Biochem. Biophys. Res. Commun. 366 2008 123 128
6. Garrison K.R., Shemilt I., Donell S., Ryder J.J., Mugford M., Harvey I., Song F., Alt V., 2010. Bone morphogenetic protein (BMP) for fracture healing in adults. Cochrane Database Syst. Rev. CD006950, http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD006950.pub2/abstract
7. Gendron S., Boisvert M., Chetoui N., Aoudjit F. Alpha1beta1 integrin and interleukin-7 receptor up-regulate the expression of RANKL in human T cells and enhance their osteoclastogenic function Immunology 125 2008 359 369
8. Habauzit V., Horcajada M.N. Phenolic phytochemicals and bone Phytochem. Rev. 7 2008 313 344
9. Kojima T., Yamaguchi M., Kasai K. Substance P stimulates release of RANKL via COX-2 expression in human dental pulp cells Inflamm. Res. 55 2006 78 84
10. Lee E.Y., Seo M., Juhnn Y.S., Kim J.Y., Hong Y.J., Lee Y.J., Lee E.B., Song Y.W. Potential role and mechanism of IFN-gamma inducible protein-10 on receptor activator of nuclear factor kappa-B ligand (RANKL) expression in rheumatoid arthritis Arthritis Res. Ther. 13 2011 R104
11. Lei S.F., Wu S., Li L.M., Deng F.Y., Xiao S.M., Jiang C., Chen Y., Jiang H., Yang F., Tan L.J., Sun X., Zhu X.Z., Liu M.Y., Liu Y.Z., Chen X.D., Deng H.W. An in vivo genome wide gene expression study of circulating monocytes suggested GBP1, STAT1 and CXCL10 as novel risk genes for the differentiation of peak bone mass Bone 44 2009 1010 1014
12. Lin Y., Murray M.A., Garrett R.I., Gutierrez G.E., Nyman J.S., Mundy G., Fast D., Gellenbeck K.W., Chandra A., Ramakrishnan S. A targeted approach for evaluating preclinical activity of botanical extracts for support of bone health J. Nutri. Sci. 3 e13 2014 1 11
13. Liu Y.Z., Dvornyk V., Lu Y., Shen H., Lappe J.M., Recker R.R., Deng H.W. A novel pathophysiological mechanism for osteoporosis suggested by an in vivo gene expression study of circulating monocytes J. Biol. Chem. 280 2005 29011 29016
14. Looker A.C., Melton L.J., Harris T.B., Borrud L.G., Shepherd J.A. Prevalence and trends in low femur bone density among older US adults: NHANES 2005-2006 compared with NHANES III J. Bone Miner. Res. 25 2010 64 71
15. Markowitz V.M., Chen I-M., Kosky A. Gene expression data management: a case study Advances in database technology 2002 EDBT 722 731
16. Markowitz V.M., Topaloglou T. Applying data warehouse concepts to gene expression data management Proceedings of the IEEE 2nd International Symposium on Bioinformatics and Bioengineering Conference, 2001 4-6 Nov 2001
17. Matayoshi T., Goto T., Fukuhara E., Takano H., Kobayashi S., Takahashi T. Neuropeptide substance P stimulates the formation of osteoclasts via synovial fibroblastic cells Biochem. Biophys. Res. Commun. 327 2005 756 764
18. McLean R.R. Proinflammatory cytokines and osteoporosis Curr. Osteoporos. Rep. 7 2009 134 139
19. Nabipour I., Larijani B., Vahdat K., Assadi M., Jafari S.M., Ahmadi E., Movahed A., Moradhaseli F., Sanjdideh Z., Obeidi N., Amiri Z. Relationships among serum receptor of nuclear factor-kappaB ligand, osteoprotegerin, high-sensitivity C-reactive protein, and bone mineral density in postmenopausal women: osteoimmunity versus osteoinflammatory Menopause 16 2009 950 955
20. Nakamura K., Saito T., Kobayashi R., Oshiki R., Oyama M., Nishiwaki T., Nashimoto M., Tsuchiya Y. C-reactive protein predicts incident fracture in community-dwelling elderly Japanese women: the Muramatsu study Osteoporos. Int. 22 2011 2145 2150
21. Post T.M., Cremers S.C., Kerbusch T., Danhof M. Bone physiology, disease and treatment: towards disease system analysis in osteoporosis Clin. Pharmacokinet. 49 2010 89 118
22. Scherf U., Ross D., Waltham M., Smith L.H., Lee J.K., Tanabe L., Kohn K.W., Reinhold W.C., Myers T.G., Andrews D.T., Scudiero D.A., Eisen M.B., Sausville E.A., Pommier Y., Botstein D., Brown P.O., Weinstein J.N., 2000. A gene expression database for the molecular pharmacology of cancer, Nature Genet. 24, 236-244.
23. Steinhoff M.S., von Mentzer B., Geppetti P., Pothoulakis C., Bunnett N.W. Tachykinins and their receptors: contributions to physiological control and the mechanisms of disease Physiol. Rev. 94 2014 265 301
24. Teletchea S., Stresing V., Hervouet S., Baud'huin M., Heymann M.F., Bertho G., Charrier C., Ando K., Heymann D. Novel RANK antagonists for the treatment of bone-resorptive disease: theoretical predictions and experimental validation J. Bone Miner. Res. 29 2014 1466 1477
25. Terpos E., Fragiadaki K., Konsta M., Bratengeier C., Papatheodorou A., Sfikakis P.P. Early effects of IL-6 receptor inhibition on bone homeostasis: a pilot study in women with rheumatoid arthritis Clin. Exp. Rheumatol. 29 2011 921 925
26. Vasikaran S.D. Utility of biochemical markers of bone turnover and bone mineral density in management of osteoporosis Crit. Rev. Clin. Lab. Sci. 45 2008 221 258
27. Wang L., Zhao R., Shi X., Wei T., Halloran B.P., Clark D.J., Jacobs C.R., Kingery W.S. Substance P stimulates bone marrow stromal cell osteogenic activity, osteoclast differentiation, and resorption activity in vitro Bone 45 2009 309 320
28. Wilson T.J., Nannuru K.C., Futakuchi M., Sadanandam A., Singh R.K. Cathepsin G enhances mammary tumor-induced osteolysis by generating soluble receptor activator of nuclear factor-kappaB ligand Cancer Res 68 2008 5803 5811
29. Xiao P., Chen Y., Jiang H., Liu Y.Z., Pan F., Yang T.L., Tang Z.H., Larsen J.A., Lappe J.M., Recker R.R., Deng H.W. In vivo genome-wide expression study on human circulating B cells suggests a novel ESR1 and MAPK3 network for postmenopausal osteoporosis J. Bone Miner. Res. 23 2008 644 654
30. Xu X.H., Dong S.S., Guo Y., Yang T.L., Lei S.F., Papasian C.J., Zhao M., Deng H.W. Molecular genetic studies of gene identification for osteoporosis: the 2009 update Endocr. Rev. 31 2010 447 505